CONTOUR DIABETES app (UK) vs. Omnipod® 5 App Utilizzo e statistiche

The easy-to-use CONTOUR™DIABETES app is designed for adults of all ages with diabetes.(1) Since 2016, there have been over 1.2 million downloads.(2) Start your download and enjoy your journey. People using the system say they:(1,3) • better understood their diabetes • significantly decreased HbA1c values • didn't find it to be a hassle that compromised their quality of life The CONTOUR™DIABETES app syncs with a CONTOUR™ connected meter for seamless blood glucose monitoring. This easy-to-use app can give you a better understanding of how your daily activities affect your blood glucose results to help you manage your diabetes. In addition to using the CONTOUR™DIABETES app, always consult with your Health Care Professional before making any changes to your diet, exercise or treatment regimen. The CONTOUR™DIABETES app presents your blood glucose results in a simple and easy-to-review way that’s personalized to you. Download the CONTOUR™DIABETES app today and start receiving meaningful information on your progress, with some of the latest features... • My Patterns – can notify you of trends in your blood glucose readings, by presenting you with potential causes and guidance on how you may improve • Test Reminder Plans – let you optimize your testing regime to give you results that are more insightful • Record – allows you to record events such as diet, activities and medication, and also add photos, notes or voice memos to help put your results in context • View – if you use insulin and/or log your carbs, you can now see your insulin doses, carb intakes and blood glucose results in one simple view • Share – give your healthcare professional greater insight with the easy-to-read diary report – send this report in advance or take it with you on the day of your appointment • Apple Health™ - is now integrated with the CONTOUR™DIABETES app Learn more about the CONTOUR™DIABETES app and CONTOUR™ connected meters at: www.diabetes.ascensia.com compatibility.contourone.com Note: Screenshots are for illustration purposes. Availability of blood glucose meter model based on country of purchase. Units of measurement in the app will match that of your synced meter. For more information, please refer to the user guide for your CONTOUR™ connected meter. © 2021 Ascensia Diabetes Care Holdings AG. All rights reserved. Manufacturer Ascensia Diabetes Care Holdings AG Peter Merian-Strasse 90 4052 Basel, Switzerland www.diabetes.ascensia.com Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. 1. Fisher W et al. User Experience with a New Smartphone Application for Blood Glucose Monitoring (BGM) in an Information-Motivation-Behavioral Skills (IMB) Model Study. Poster presented at the 12th International Conference on Advanced Technologies & Treatments For Diabetes (ATTD); February 20-23, 2019; Berlin, Germany. 2. Data on file. Ascensia Diabetes Care. DCAM-147-5682. 3. Fernandez-Garcia D et al. The ICONE Study: A multicenter evaluation of the impact of CONTOUR™NEXT ONE and CONTOUR™DIABETES app on Self-Management and Adherence in Insulin-Treated Patients with Diabetes. ePoster presented at European Endocrinology Society Congress (ECE), 5-9 September 2020.

Google Play Store
Gratis
Settore Medico

Rank di utilizzo

- -

Omnipod® 5 App

The Omnipod® 5 Automated Insulin Delivery System is the only FDA cleared, tubeless automated insulin delivery system that integrates with Dexcom G6 and G7 CGM and automatically adjusts insulin delivery to manage blood glucose with no multiple daily injections and zero fingersticks*. Simple and automated insulin delivery with the Omnipod 5 System is made possible with the tubeless Omnipod 5 Pod, the integrated Dexcom G6 and G7 continuous glucose monitoring systems and the Omnipod 5 App installed on an Insulet-provided controller or on your personal compatible smart phone**. The Omnipod 5 App allows you to select a basal profile, target glucose and bolus settings, activate and deactivate the Pod, connect with the Dexcom G6 and G7 Continuous Glucose Monitoring Systems, and select an insulin delivery mode. For more information on Omnipod 5 please download the Omnipod 5 Simulator App or visit: https://www.Omnipod.com/what-is- Omnipod/Omnipod-5 * Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. **For a list of the latest compatible smartphones, please visit: https://www.Omnipod.com/compatibility Intended Use:  The Omnipod 5 App is part of the Omnipod 5 Automated Insulin Delivery System. The Omnipod 5 System is for prescription use only. The Omnipod 5 System is indicated for use by individuals with Type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide at www.omnipod.com for complete safety information including indications, contraindications, warnings, cautions, and instructions. Do not use the Omnipod 5 App without receiving the proper training from your healthcase provider. This app store should not be used as your first point of contact to resolve technical or customer services issues. In order to protect your privacy and personal information, and to promptly resolve any technical or customer services issues you are having with any Insulet product, please contact Insulet customer support at 1-800-591-3455 or at Omnipod.com/contact-us. © 2024 Insulet Corporation. Omnipod, SmartAdjust, Podder, PodderCentral, the Omnipod logo, and Simplify Life are trademarks or registered trademarks of Insulet Corporation. All rights reserved. Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. and used with permission. The use of third party trademarks does not constitute an endorsement or imply a relationship or other affiliation. All other trademarks are the property of their respective owners.